Primary Health Properties PLC A leading investor in critical healthcare infrastructure in the UK and Ireland Interim results for the six months to 30 June 2026 30 July 2026 Image: Ballincollig Enhanced Community Care Centre, Westfield 1 Interim…
Primary Health
Properties PLC
A leading investor in critical healthcare
infrastructure in the UK and Ireland
Interim results for the six
months to 30 June 2026
30 July 2026
Image: Ballincollig Enhanced Community Care Centre, Westfield
1
Interim results - opening remarks
We have delivered a strong operational performance, with
positive rental growth and growing volume of asset
management and development activity
Disciplined cost control of overheads and finance costs,
alongside the positive contribution from the merger with
Assura, have driven another period of earnings growth
In H1 we have focused on delivering key post-transaction
objectives, of integration and synergies, deleveraging and
refinancing, which all remain on track
PHP has continued its 30-year track record of dividend
growth from our critical healthcare infrastructure assets
which deliver long-dated, secure and growing income
Well positioned for growth in the evolving healthcare
markets which have strong fundamental investment
characteristics and attractive future opportunity
Image: Laya Health & Wellbeing Private Clinic, Cork
Interim results presentation H1 2026
2
81nidZpGqzkSDMpD
H1 Highlights: Earnings growth driven by operational activities and
boosted by merger with Assura
The combination is delivering earnings
growth, supported by our regular
operational activities which drive
shareholder value
PHP is an income compounder now in
our 30th consecutive year of dividend
growth
+9%
Growth in adjusted EPS
versus H1 2025
7.3p
Annualised dividend based on
current quarterly payments
Notes: 1 3.2% on an annualised basis – see slide 10. 2 Excluding Axis PHP overheads and direct vacancy costs
Positive trend in rental growth
Enhanced volume of asset
management deals
Close control on overheads
+6%
Uplift on reviews
settled1
29
Asset management
deals in H1
<9%
Target EPRA cost
ratio2
Resilient asset class with stable
net asset value
104p
Growing pipeline of
opportunities
£100m
Adjusted NTA
Current pipeline
Interim results presentation H1 2026
3
81nidZpGqzkSDMpD
H1 Highlights: Transaction objectives remain on track
Integration & synergies
materially delivered
Deleveraging plan
remains on track
Acquisition bridging facility
nearly repaid
✓ 92% of cost synergies already delivered
✓ Exclusive terms agreed on £0.7bn
private hospital joint venture with global
institutional investor
✓ £800m refinancing completed & further
£400m post period end, realising 40bps
reduction to credit margins
✓ Combined team with best of both
focused on generating value through
rent reviews, asset management and
risk-controlled development
✓ £103m transfer of UK primary care
assets to existing JV with USS on track
to exchange shortly
✓ Proceeds from JV and disposals will be
used to repay acquisition bridging
facility before seeking PHP credit rating
and targeting strong investment grade
Progress: Near completion
Progress: Well advanced
✓ Integration substantially complete
✓ Additional £8m of targeted disposals
Progress: Awaiting JV proceeds
Interim results presentation H1 2026
4
81nidZpGqzkSDMpD
New private hospital JV – exciting opportunity in a growth sector
Exclusive terms agreed for £0.7bn JV
▪ New JV with global long term institutional investor
▪ 50/50 ownership on day 1
▪ New partner is long-established with good knowledge of
the healthcare sector through other investments
▪ PHP asset manager receiving fee income with incentives
▪ Due diligence advanced, on target for summer
completion
Strategic benefits
Releasing capital for deleveraging
▪ JV seeded with £0.7bn private hospital portfolio
▪ Proceeds to reduce leverage from Assura combination in line with strategy
▪ Significant and positive delivery of one of the post-merger priorities
Unlocks growth capital
▪ Maintains financial interest in and access to fast-growing market
▪ Retains the upside we see from this portfolio of assets
▪ Potential for future acquisition and development growth in a JV structure
Stronger return on capital
Parkside Hospital, Wimbledon
▪ Higher earnings yields offered by these assets which are performing well
▪ Asset management, development and performance fees will boost returns
Interim results presentation H1 2026
5
81nidZpGqzkSDMpD
PHP’s capital structure and financial policies
Today
Unsecured borrowings
LTV
74%
57%
Short term Future target
trajectory
c.80%
See chart
90%
40-50%
Proforma LTV progression
60%
55%
50%
Target
Range
45%
Net debt/EBITDA
10.4x
<10x
<9x
40%
Interest cover
2.6x
Credit rating
BBB+
(Assura only)
Average interest rate
3.8%
Proportion of net debt
fixed or hedged
73%
2.9x
3x
0%
BBB+
(whole group)
c.3.5%
c.80%
90%
Today
JV disposals
H2 rental growth Capital recycling
& valuation
Future target
The secure nature of our income means we are
comfortable operating outside of our policies
for a short period
Interim results presentation H1 2026
6
Strong financial results
Image: Station Medical Centre, Hereford
Interim results presentation H1 2026
7
Strong H1 2026 performance reflecting the benefits of the merger
Performance
Six months to Jun 2026
Six months to Jun 2025
Change
Net rental income (£m)
176
79
+123%
Adjusted earnings (£m)
98
47
+109%
Adjusted earnings per share (pence)
3.8p
3.5p
+9%
Dividend per share (pence)
3.65p
3.55p
+3%
Dividend cover1
103%
100%
+3ppts
£4m / +3.2%
£2m / +3.0%
+£2m
18
20
-£2m
8.7%
9.8%
-110bps
30 Jun 2026
31 Dec 2025
Change
£6.0bn
£6.0bn
Gross annual passing rent roll (£m)
345
342
+£3m
Adjusted NTA per share (pence)
104p
104p
10.4 years
10.8 years
-0.4 years
99%
99%
LFL rental growth (£m) / annualised increase from reviews (%)
Revaluation gain (£m)
EPRA cost ratio2
Position
Investment property (£bn)
WAULT
Occupancy
Notes: 1 Dividend cover calculated based on absolute adjusted earnings versus dividends paid. 2 Excluding Axis PHP overheads and direct vacancy costs
Interim results presentation H1 2026
8
Financing – strong progress on post-merger objectives and
becoming fully unsecured
£1.2bn acquisition bridging loan substantially
refinanced
▪ £0.9bn cancelled to date following various
refinancing steps since acquisition
▪ Remaining £260m to be cleared as part of
deleveraging plans in place
£800m refinancing completed in June 2026
▪ £300m term loan and £500m RCF (across 2
tranches) put in place with 8 banks including 3 new
counterparties on unsecured basis
▪ Replaces £1,055m of legacy facilities (including
£335m of the bridging loan)
New £400m facility completed in July 2026
Benefit of scale reflected in debt cost synergies
Credit margin 40bps cheaper than facilities replaced
£3.8bn £3.4bn £301m
Total debt
facilities
3.8%
Weighted average
interest rate
Net debt
drawn
4 yrs
Average weighted
debt maturity
Liquidity headroom after
capital commitments
74%
Proportion of total
facilities unsecured
▪ New 2-year term loan to refinance portion of
bridging loan
Interim results presentation H1 2026
9
Positive trend in rental growth continued in H1 2026
▪ Enlarged group remains focused on delivering organic
rental growth from existing assets
▪ Total annual rent roll growth of £4 million, equivalent
to 3.2% on an annualised basis in H1 2026 across
combined portfolios
Number Previous rent Rent increase Increase
Increase
(per annum) (per annum)
total annualised
£m
£m
%
%
Review type
Primary care – open market
147
24
1.5
6.3%
2.0%
Primary care – indexed
137
15
1.2
7.5%
3.8%
Primary care – fixed
18
3
0.2
6.8%
3.1%
▪ Evidence for rent reviews strengthened by merger
and data sharing across combined portfolio
Primary care – total
302
42
2.9
6.8%
2.8%
▪ Private hospitals continue to perform very strongly
Private hospitals –
indexed/fixed
15
31
1.2
3.8%
3.7%
UK – total
317
73
4.1
5.5%
3.2%
Ireland – indexed
14
1
0.1
17.3%
4.1%
Total – all reviews
331
74
4.2
5.7%
3.2%
▪ Improving open market rent review performance for
primary care assets with an additional £1.5 million, an
increase of 6.3% over the previous passing rent
6.3%
Uplift generated on 147 OMV rent
reviews completed in H1 2026
Interim results presentation H1 2026
10
Asset management & development pipelines provide vital
rental evidence
Asset management and development
pipelines provide vital rental evidence
▪ +13% uplift on rents in asset management
pipeline
▪ 68 schemes, uplift to £218psm from
£193psm
300
+25-30%
250
▪ £279psm average rents on development
pipeline providing evidence for rent reviews
200
▪ Use of existing primary care joint venture
unlocks schemes due to cost of capital
advantage
150
▪ Benefit of combination seen in growing
asset management and development
pipelines
Rent per square metre progression
£psm
+10-15%
c.260
c.280
c.220
c.200
100
50
0
Current portfolio
average
Asset management
pipeline
2025 development
completions
Development pipeline
Interim results presentation H1 2026
11
Positive steps to manage earnings growth
Net rental
income growth
EPRA cost
ratio control &
synergies
Liability
management
EPS
growth
Contracted rent £345m
/ H1 RRs +3.2%
Current ratio
8.7%
Average interest cost
3.8%
H1 2026:
3.8p / +9%
▪ Portfolio that delivers
consistent rental
growth
▪ Track record of EPRA
Cost Ratio amongst
lowest in sector,
targeting c.9%
▪ Enhancement of
portfolio through
additions, disposals
and asset
management to
enhance returns
▪ Acquisition synergies
being delivered on
schedule
▪ Transition to fully
unsecured lending
structure
▪ Acquisition facilities to
be refinanced in 2026
▪ Strong investment
grade credit rating
targeted for PHP
▪ PHP is operating in a sector with
strong growth prospects, across
primary care and private
hospitals
▪ Well-positioned to capture asset
enhancement, development and
acquisition opportunities
Interim results presentation H1 2026
12
A portfolio with structural growth
Image: Stourside Hospital, Stourbridge
Interim results presentation H1 2026
13
PHP operates in three resilient healthcare markets with significant
growth opportunities
Primary care – UK
Primary care – Ireland
Private hospitals
c.£4.9bn
c.£0.3bn
c.£0.8bn1
15%
15%
5%
Sustained growth in demand for healthcare facilities
✓
✓
✓
Attractive fundamental tailwinds
✓
✓
✓
Long income (> 20-year leases) as standard
✓
✓
✓
Strong and secure covenant
✓
✓
✓
Rental growth linked to inflation
✓2
✓
✓
Well-located, highly maintained, best-in-class assets
✓
✓
✓
Current portfolio
Estimated market share
Sector investment characteristics
All sectors offer attractive structural trends for investment which can be accessed using PHP’s unique sector expertise
Notes: 1 £0.7bn of private hospital portfolio under discussion for disposal. 2 Linkage to inflation through construction cost inflation in asset management and developments which provide evidence for rent reviews
Interim results presentation H1 2026
14
Neighbourhood Health Centres – NHS guidance published
NHS has published guidance on what constitutes an NHC
▪ Next step in succession of announcements from the current
Government, stemming from the NHS 10-year plan
▪ Focus on neighbourhood health model, moving more services
out of hospitals and into communities
▪ New Prime Minister has spoken of need to further join up social
care with the NHS, further emphasising preventive care
First tranche of 27 NHCs announced
3 are PHP assets
▪ Fleetwood, Shefford and St Helens have all be
identified by NHS England as in the first tranche
of NHCs
▪ Capital will be available for improvements to
enable a greater range of services to be provided
▪ Bespoke plans at each location based on local
needs
▪ All of which points to need for additional investment in
buildings that PHP can deliver
Minimum core components of an NHC
▪ GP and PCN staff (group and individual
consulting rooms)
▪ Community Health team including
social care staff (team rooms and
consulting space)
Additional components expected
▪ Mental health services
▪ Hubs for babies and families, women,
debt advice, healthy living
Shefford
St Helens
▪ Minor diagnostics (blood, ultrasound,
echo, spirometry)
▪ Larger consulting rooms for ENT,
gynae and other community clinics
▪ Urgent treatment and minor injury
centres
▪ Shared spaces
▪ Out of hours team
Guidance: https://www.england.nhs.uk/long-read/neighbourhood-health-centre-guidance-for-regions-and-integrated-care-boards/
Fleetwood
Interim results presentation H1 2026
15
On site at Weston-super-Mare to enhance neighbourhood services
Nature of scheme
▪ Five storey new build development bringing
together a number of NHS services
▪ Meets requirements of neighbourhood health
centre, majority of space let to local ICB with sub
let to GPs and community interest company
supporting adult and child health services
▪ NHS capital used to unlock the scheme
Benefits for PHP
▪ Funded through existing JV, so capital light £19m scheme but only £2.3m cost for PHP
▪ 25-year inflation linked lease
▪ Yield on cost >8% - boosted by both ongoing
management fee and initial development
management fee
▪ Unlocks significant rental evidence well ahead of
local averages
Interim results presentation H1 2026
16
On site in Tetbury for new medical centre to support population growth
Nature of scheme
▪ Local population growth and new housing
schemes generated healthcare provision as a
s.106 requirement
▪ New building will house relocating GP practice
and pharmacy
▪ Partnership with the housing developer to
deliver the 1,070 sqm scheme
Benefits for PHP
▪ Funded through existing JV, so capital light –
£5m scheme, only £1m cost to PHP
▪ 30-year lease with fixed rental uplifts
▪ Yield on cost >9% - boosted by both ongoing
management fee and initial development
management fee
▪ Unlocks significant rental evidence well ahead of
local averages
Interim results presentation H1 2026
17
Growing pipeline of risk-controlled development opportunities
On site
Immediate pipeline
£12m
PHP’s 20% share of capital for 4
new development projects
Weston-super-Mare
Brockworth
Yield on cost expected to
be >12%
Coleford
• Supports Government priority to create neighbourhood
health facilities
Tetbury
• Schemes generate strong rental evidence for rent reviews
• Capital light for PHP as pipeline schemes expected to be funded
through existing JV
Youghal
• Strong double-digit returns through generation of development
fees and ongoing management fees
Interim results presentation H1 2026
18
Completed neighbourhood asset management project in Wakefield
Nature of scheme
▪ Health hub serving over 27,000 patients
▪ Site expansion - 13 consulting rooms added
▪ Additional capacity for enhanced communitybased services, easing pressure on hospitals
▪ Services include minor operations,
out-of-hours, maternity and midwifery, and
musculoskeletal (MSK)
Benefits for PHP
▪ £4m capital works improvement to asset with
new 25 -year lease term commenced
▪ Asset management delivers >6% yield on cost
▪ Positive rental tone for other local properties
▪ Improvement in energy efficiency, with BREEAM
rating of Very Good expected
Interim results presentation H1 2026
19
On site at new build private hospital in Peterborough
Nature of scheme
▪ New build £21m project to develop new day case
surgery unit that will create additional capacity
in local area
▪ Focus on delivering NHS-referred procedures,
easing pressure on NHS locally
▪ Also contains outpatient clinic and
diagnostics unit
Benefits for PHP
▪ 6% yield on cost, supported by long lease and
inflation-linked uplifts
▪ Builds on existing relationship with Ramsay
Health Care, a tried and tested model, adapted to
local requirements, developing 6 hospitals over
the last 10 years
▪ Will transfer to private hospital JV when complete
Interim results presentation H1 2026
20
Closing remarks
Image: Celbridge Primary Care Centre
interim results presentation H1 2026
21
PHP: a proven platform in a growing healthcare sector
PHP’s portfolio – modern
healthcare properties
Operating in a
growth sector
▪ The UK’s largest healthcare REIT, with
over 1,100 properties across the UK and
Ireland at a combined valuation of
£6bn, 10-year WAULT and 99%
occupancy
▪ Demographic tailwind created by
growing and ageing population,
generating demand for health services
▪ Low risk, long term, non-cyclical,
secure government backed income
▪ Continued shift of services into primary
care setting, supported by the NHS 10year plan and Neighbourhood Health
Centre model
▪ Progressive income generation with
30-year track record of consistent
dividend growth
▪ Significant investment required with
50% of the existing UK primary care estate
deemed “not fit for purpose”
▪ Confidence in rental growth outlook,
targeting >3% annual growth
▪ Relationships with key health stakeholders
place PHP at the centre of the solution to
deliver on the Government’s plans
Image: St Clement’s Surgery, Winchester
Sector-leading financial
performance & cost control
▪ Active management of portfolio
central to the strategic priorities of
stable income, growth through
investment and a disciplined approach
to leverage
▪ Strong control on overhead with
EPRA Cost Ratio <10%
▪ 100% of termed out debt fixed or hedged,
with a low average cost of 3.8%
▪ Enhanced total property returns and
delivering shareholder value, with 8%
CAGR on 30-year dividend track record
Interim results presentation H1 2026
22
Closing remarks
Transaction objectives remain on track
30 years of dividend growth –
on track to becoming a Dividend King
▪ Synergies materially delivered and integration
substantially complete
▪ Deleveraging plan is well advanced
▪ Acquisition bridging facility to be repaid from JV proceeds
Dividend growth driven by quality of our portfolio,
operational activities and scale benefits following
combination with Assura
1997-2026 CAGR 8%
4.1p 4.3p
▪ PHP is an income compounder now in our 30th consecutive
year of dividend growth
4.9p 5.0p
5.4p
5.6p
6.2p
6.7p
7.3p1
7.1p
3.8p
3.4p
▪ Earnings growth is supported by focus on operational
excellence which drives shareholder value
▪ Positive trend in rental growth
4.4p 4.5p
4.6p 4.8p
5.1p 5.3p
5.9p
6.5p
6.9p
1.4p 1.5p
1.8p
2.0p
2.3p
2.5p
2.8p
3.0p
0.8p
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
▪ Close control on costs
1997
▪ Enhanced volume of asset management deals
▪ Growing pipeline of opportunities
1 Annualised dividend based on rate declared – 3 dividends have been declared and paid, final quarterly dividend expected to be paid in November
Interim results presentation H1 2026
23
Appendices
Image: Shirley Health Partnership, Southampton
Interim results presentation H1 2026
24
Attractive strategy and financial
framework
Operating policies
▪ Progressive dividend paid on a quarterly basis
▪ 80% to 90% government backed income target
▪ Focus on organic rental growth >3% to deliver sector leading, risk
adjusted total property returns
▪ Long income with occupiers on new or regeared leases typically in
excess of 20 years
▪ Risk controlled and capital light asset management and development
projects
Financial framework
▪ Targeting strong investment grade credit rating of BBB+ or above
▪ LTV target of 40% to 50%
▪ Net debt to EBITDA target <9.5x
▪ Interest cover target of >2.5x with >90% of debt fixed or hedged
▪ Tight control on costs and overheads with one of the lowest EPRA cost
ratios in the sector (sub 10%)
Image: Trinity Medical Centre, Wakefield
Interim results presentation H1 2026
25
The UK’s largest healthcare REIT with a £6bn property portfolio
offering secure, long-dated income
North West
11%
Scotland & NI
5% by value
North East &
Yorkshire
17%
Ireland
6%
Midlands &
East Anglia
22%
Wales
6%
London
14%
Portfolio
£6bn
Rent roll
£345m
Govt-backed
76%
Indexed/fixed uplifts
40%
Occupancy
99%
WAULT
South West
6%
South East
13%
10.4yrs
Interim results presentation H1 2026
26
Key portfolio metrics
Primary care
– UK
Primary care
Private
– Ireland hospitals
JVs &
other
Total
Rent roll
(£m)
Number of assets
1,057
28
33
22
1,140
Value (approx.)
£4.8bn
£0.3bn
£0.8bn
£0.1bn
£6.0bn
90
Rent roll
£277m
£20m
£45m
£3m
£345m
WAULT
8.0 yrs
17.5 yrs
21.5 yrs
18.0 yrs
10.4 yrs
80
Income expiry profile
70
Rent review basis
OMV
75%
2%
2%
6%
60%
Indexed
20%
97%
87%
73%
34%
Fixed
5%
1%
11%
21%
6%
50
GP / Govt
86%
89%
95%
76%
40
Pharmacy
9%
6%
4%
7%
Nuffield
38%
5%
Circle
16%
2%
Spire
14%
2%
Ramsay
13%
2%
Genesis
7%
1%
HCA
5%
1%
PPG
3%
0%
Laya
3%
0%
Other
5%
5%
1%
1%
4%
Tenant covenant
60
30
20
10
0
Holding <3 years 4-5 years 5-10 years
over
Primary care - UK
Primary care - Ireland
10-15
years
15-20
years
Private hospitals
20-25
years
25 years
JVs & other
Interim results presentation H1 2026
27
Portfolio statistics
Capital value
Number
Value (£m)
%
Geographical analysis
Number
Value (£m)
%
£10m
130
2,187
37
Midlands & East Anglia
256
1,328
22
£5m - £10m
244
1,644
28
North East & Yorkshire
225
1,023
17
£3m - £5m
321
1,261
21
London
120
813
14
£1m - £3m
409
845
14
South East
173
790
13
<£1m (inc. land £5m)
36
35
North West
105
670
11
1,140
5,972
Republic of Ireland
29
369
6
Wales
83
336
6
South West
87
337
6
Scotland & NI
62
306
5
1,140
5,972
100
Total
£1-3m
<£1m
14%
37%
£3-5m 21%
£10m
Total
£5.4m 1,538k
Average lot size
of portfolio
28%
Total area of portfolio
(square metres)
£5-10m
Interim results presentation H1 2026
28
Experienced Executive Leadership Team
Richard Howell
Mark Davies
CFO
CEO
Emma Mackenzie
COO
Steven Noble
CIO
Sarah Taylor
CPO
Interim results presentation H1 2026
29
UK Primary Care
Attractive market
opportunity
Driving returns from
existing portfolio
Access to pipeline for
growth
Value enhancing
use of capital
Strong political will to move
more services out of hospitals
and into the community
Day-to-day focus on generating
growth from rent reviews
Growing pipeline of riskcontrolled developments,
leveraging expertise acquired
through the Assura deal and to
support NHS in delivery of
Neighbourhood Health Centres
Current development
opportunities funded through
existing JV with USS – capital
light, with stronger returns on
capital, and still unlocking
rental evidence
Significant opportunity to
replace out-dated and
underinvested GP estate with
modern facilities
Asset management
opportunities built from our
track record and strength of
relationships with the NHS
▪ 1,100 sq.m GP surgery and pharmacy currently on site in Tetbury, Gloucestershire
▪ c.£5m total cost, funded through our JV with USS and therefore PHP capital
contribution is only 20%, with returns boosted by development fee and ongoing
asset management fee
On site
development at
Tetbury
▪ 30-year lease in place with fixed 2.5% per annum uplifts
Tetbury
▪ Initial rent set at level which sets positive rental tone in region for rent reviews on
other properties
Interim results presentation H1 2026
30
Primary Care Ireland
Attractive market
opportunity
Driving returns from
existing portfolio
Centralised HSE plan to roll out
primary care centres (PCCs) and
enhanced community care
centres (ECCCs) to provide
easier access to healthcare for
largely rural population
Irish assets are generally of
larger scale, bringing more
services together in one
location, with 5 yearly rent
reviews linked to Irish CPI
Access to pipeline for
growth
Value enhancing
use of capital
Local team (Axis PHP) and
strength of relationships in
Ireland give us good access to
pipeline of development
schemes
Ability to enhance returns by
funding new opportunities with
Euro debt which is generally at
lower rates than Sterling
Potential for opportunistic
acquisitions with asset
management angle
▪ €15m new build development in Birr, completed June 2026
▪ c.5,000 sqm health campus, accommodating HSE, GPs, local TUSLA team and an
ambulance hub
Development
completion at Birr
▪ 25-year lease in place with CPI-linked rent reviews
Birr
▪ HSE to operate services in a community setting, including occupational therapy,
speech and language therapy, paediatric physiotherapy, social work services and
dietetics.
Interim results presentation H1 2026
31
Private hospitals
Attractive market
opportunity
Sustained growth in
independent hospital revenues,
across three payor mix (PMI,
NHS-referred and self-pay)
Improved profitability and rent
cover is driving need for further
estates investment and
additional capacity
Driving returns from
existing portfolio
Access to pipeline for
growth
Private hospital portfolio has
delivered strong rental growth,
with index-linked reviews as well
as improving rent cover which
now stands at 2.8x
Currently on site with one new
build project in Peterborough
and building pipeline of future
schemes
Relationships with private
providers allow identification of
asset management projects such
as Edgbaston
Value enhancing
use of capital
Well-advanced on establishment
of joint venture which will boost
returns through asset
management fees and
opportunities to fund
development projects
▪ 120 sqm extension at Edgbaston Hospital, £1.3m capex with 8% yield on cost
▪ Extension to building to allow additional MRI scanner to be installed and create
space for on site imaging analysis. New equipment brings the latest MRI
technology to enhance the quality of services available to patients. Additional
capacity in region allows NHS, insured and self pay patients to be seen quicker
Asset management
project at
Edgbaston Hospital
New MRI scanner at Edgbaston
▪ Example of attractive opportunities in private market which is experiencing
sustained growth
Interim results presentation H1 2026
32
Best of both approach to combination has enhanced Group capabilities
Asset management
Development
PHP’s strong track record and approach, along with greater breadth of
relationships across enlarged team, creates more opportunities
Assura acquisition has strengthened development capabilities, not just in
primary care but also in private hospital market
Opportunities also to apply this approach to the Assura portfolio to drive
revenue growth
Can utilise relationships across enlarged team to generate the
development opportunities to offer strong returns for shareholders
✓ Relationship approach to generate additional opportunities focusing
✓ Primary care UK – gradual unlocking of pipeline as necessity for
✓ Opportunities with NHS PS – lease re-gears across multiple assets in
✓ Ireland – HSE central plan means there is a consistent flow of new
✓ Solar panel commercialisation – trial scheme completed to generate
✓ Private hospitals – larger lot size opportunities with proven operators
✓ Asset management schemes generate rent increases which act as
✓ Development projects have rents set at levels which act as evidence
on regions of strength
one deal offering efficiency for both NHS and PHP
returns from sustainability improvements
evidence for rent reviews
Image: Hadrian Health Centre, Wallsend
investment grows. Funded through existing JV
schemes for our Irish colleagues to target
as market continues to grow
for rent reviews
Interim results presentation H1 2026
33
Healthcare trends support compelling property opportunity
Sustained growth in waiting lists creates need
for primary care infrastructure & opportunity
for private sector
9m
8m
Political will to improve NHS performance
through moving more services out of hospital
and into community buildings
UK Government priorities
NHS England Total Waiting List (Source: NHS England)
The number of private hospitals has not kept
pace with sector revenue growth – creating
opportunity for investment
£bn
8.0
7.5
7m
Hospital to community
6m
6.5
6.0
4m
5.5
3m
2m
1.5
Jan-25
Nov-25
Mar-24
Jul-22
May-23
Sep-21
Jan-20
Nov-20
Mar-19
Jul-17
May-18
Sep-16
Nov-15
Jan-15
Mar-14
Jul-12
May-13
Sep-11
Jan-10
Nov-10
0m
Sustained elevated levels of NHS waiting lists escalates
the push for more services to be delivered out of
hospitals in primary care
The independent sector plays a growing role in
supporting the NHS through referred work, and
patients more willing to self-fund
Sickness to prevention
4.5
3.5
0.0
Sustained focus from Government and NHS (10 year
plan), evidenced in the 2025 Autumn Statement
The UK Government has committed to rolling out
neighbourhood health centres across the country –
targeting 250 by 2035
Irish Government remains committed to rolling out
enhanced community care centres
209
hospitals
5.0
1.6
4.0
1m
1.3
7.0
5m
Analogue to digital
£7.8bn
Independent sector revenue growth
(Source: Laing Buisson)
2.8x
£3.4bn
200
hospitals
2010
rent cover
PMI
NHS-referred
Self-pay
2025
Independent sector revenue growth has outpaced the
growth in the number of sites meaning existing
hospitals are well-utilised
As well as enhancing metrics such as EBITDA margin
and rent cover, this creates opportunities for new
development and asset enhancement
Interim results presentation H1 2026
34
Irish portfolio – market leading portfolio quality
£350m
£20m
Current valuation
Rent roll
17 yrs
5.0%
WAULT
NIY
Tenant covenant
Rent review basis
Fixed OMV
Pharmacy
6%
97%
Indexed
Enhanced primacy care centres providing better local
healthcare access for patients
Other
Youghal Primary Care Centre
Due to complete Q1 2027,
consolidating the primary services
for the area in one enhanced
building. New site enables to HSE
to offer greater range of services
locally including physiotherapy,
dental, occupational therapy,
community mental health
services and home support.
5%
89%
Government bodies
Developments
Completed sites
Interim results presentation H1 2026
35
Private hospital portfolio – focus on quality locations and operators
£0.8bn
Current valuation
£45m
21 yrs
2.8x
Rent roll
WAULT
Fixed
Rent cover
Tenant covenant
Rent review basis
OMV
HCA
11%
Geographical diversified, with weighting to London
and South-East
GenesisCare
PPG
1
Currently on site with £21m
private hospital in Peterborough
for Ramsay Health Care, due to
complete Q1 2027.
North East
7%
Spire
Yorkshire &
Humber
North West
Nuffield
Health
5
West 3
Midlands
38%
3
London
Ramsay
Indexed
2
3
Laya Other
13%
87%
Scotland
14%
South West
16%
1
East
Midlands
2
6
6
East
Anglia
South East
Circle
Interim results presentation H1 2026
36
Independent providers offer secure tenant covenant
Established
operators with
sustained
improvement in
financial
performance
Strong average rent
cover of 2.8x
Nuffield Health
Circle Health Group
Spire Healthcare
Ramsay Healthcare UK
Most recent revenue
£1.0bn
£1.3bn
£1.6bn
£1.4bn
Estimated market share
14%
17%
Generalist
Generalist
80% private / 20% NHS
64% private / 36% NHS
73% private / 27% NHS
30% private / 70% NHS
5%
2%
2%
2%
6.5% growth in hospitals
turnover, growth in both
NHS & self-pay patients,
improved EBITDA margin
8% revenue growth, and
now profitable. Focus on
shift from general elective to
high acuity specialism
4.5% revenue growth, and
EBITDA margin of 17%
sustained in FY25 results
7% growth in revenue with
70bps improvement in EBIT
margin
Payor focus
% of PHP rent roll
Recent results commentary
Patient referral
Patient
pathways allow
operators to
optimise
revenue mix at
each location
Time for procedure
Payment
Tariff
Operator margin
Hospital charges by activity
Highest margin work,
or package price for
volume subject to local
procedure
demand and demographics
Self-pay
(c.25% of
sector
revenues)
Patient can choose surgeon
or hospital based on own
research or GP
recommendation
Typically days, based on
surgeon availability
Patient pays package fee
through hospital, or
individual payment to
hospital, surgeon &
anaesthetist
PMI (c.45%)
GP provides open referral &
patient then chooses PMI
registered surgeon
Typically days, based on
surgeon availability
PMI provider pays the
hospital, surgeon &
anaesthetist
Negotiated contracts with
specified price per
procedure
NHSreferred
(c.31%)
By GP to private hospital
taking NHS patients
On waiting list, typically
months
NHS Trust/ICS pays the
hospital
Fixed tariff NHS contracts or
Lowest margin but greatest
a block contract covering
certainty of volume
type of treatment in region
Negotiated contracts give
appropriate margins and
volume
Interim results presentation H1 2026
37
Portfolio rent review basis
Portfolio benefits from greater proportion being directly
tied to inflation metrics
▪ Improving performance seen in open market reviews
▪ Positive trend has continued
▪ Irish properties and private hospitals have delivered strong
rental uplifts backed by strong financial covenant of
occupiers
Rent by segment
Primary care
UK
Primary care
Ireland
Private
hospitals
Contracted rent roll
£277m
£20m
£45m
Typical rent review basis
OMV
Indexed (Irish CPI)
Indexed (RPI/CPI)
Typical rent review
frequency
3 yearly
5 yearly
Annual
Rent review basis
and timing
Annual
3 yearly
5 yearly
Total
54%
6%
60%
Asset management used to drive rental evidence
▪ Advanced pipeline of 65 projects across the enlarged Group
▪ Current weighted average rent of £193 psm
▪ Targeting increase of c.13% to £218 psm post completion
OMV
▪ Provides evidence, alongside developments (which
currently average £279 psm), for rent reviews
Indexed
16%
9%
9%
34%
Fixed
2%
3%
1%
6%
Interim results presentation H1 2026
38
Open market reviews outstanding – relating to 60% of the portfolio
Drivers of future rental growth
▪ Typically, 3-yearly review cycle
Open market
rent reviews
completed
2026 YTD
Number of
outstanding reviews
(current rent)
▪ Building cost inflation – captured through rents on asset
management projects and new developments
Reviews relating to calendar years:
No.
% p.a.
No.
£m
<=2021
37
1.9
121
17.5
▪ Completion of historic rent reviews
2022
25
2.4
126
16.4
▪ Replacement cost
2023
34
2.2
186
27.4
2024
21
2.4
320
45.4
▪ Building regulations and specification creep
2025
13
2.1
349
49.7
▪ Reducing the NHS carbon footprint
2026
1
1.8
185
26.0
Open market increases
131
2.2
1,287
182.4
Nil increases
16
0.0
Total open market reviews
147
2.0
▪ 1,287 open market reviews outstanding (£182m of annual rent)
▪ 656 triggered to date, £5.3m uplift expected (5.5%)
Outstanding reviews focused by region
London and
South East
North
Midlands
Wales
Eastern
Scotland
South
West
Ireland
28%
25%
22%
10%
7%
4%
4%
0%
Interim results presentation H1 2026
39
Income statement
H1 2026
Adjusted earnings
£m
H1 2026
Capital & other
£m
H1 2026
Total
£m
H1 2025
Total
£m
Full year 2025
Total
£m
Rental & other income
183
14
197
90
259
Direct property expenses
(7)
(14)
(21)
(11)
(27)
Net rental income
176
–
176
79
232
Share of profits from JVs
1
–
1
–
1
Administrative expenses
(12)
(1)
(13)
(7)
(23)
–
18
18
20
11
(67)
(11)
(78)
(24)
(88)
Other items (non-operating profit)
–
(4)
(4)
(6)
(11)
Profit before tax
98
2
100
62
122
Deferred tax and intangible assets
–
(1)
(1)
(3)
(3)
Adjusted earnings / IFRS profit after tax
98
1
99
59
119
3.5p
7.3p
4.4p
6.6p
Revaluation of property portfolio inc. JVs
Net finance costs
Adjusted EPS
IFRS EPS
3.8p
3.8p
Interim results presentation H1 2026
40
Balance sheet
30 Jun 2026
Wholly owned
£m
30 Jun 2026
Share of joint ventures
£m
30 Jun 2026
EPRA proportionally
consolidated
£m
31 Dec 2025
EPRA proportionately
consolidated
£m
Investment properties
5,935
50
5,985
5,940
Properties held for sale
5
–
5
11
Group investment property
5,940
50
5,990
5,951
Net debt
(3,422)
–
(3,422)
(3,392)
(108)
9
(99)
(107)
91
–
91
102
2,501
59
2,560
2,554
9
–
9
9
2,510
59
2,569
2,563
132
–
132
129
2,642
59
2,701
2,692
IFRS NTA per share
99p
98p
EPRA NTA per share
99p
99p
Adjusted NTA per share
104p
104p
Other net liabilities
Fair value of bank debt
IFRS NTA
Deferred tax and intangible assets
EPRA NTA
Fair value of bank debt not recognised under IFRS
Adjusted NTA
Interim results presentation H1 2026
41
Close control on EPRA Cost Ratio
EPRA Cost Ratio has stayed consistently low
12.5%
12.6%
11.5%
12.0%
Outlook
▪ £9m of cost synergies identified at time of Assura
acquisition
11.9%
9.3%
9.9%
10.1%
10.1%
9.8%
8.7%
9.0%
▪ 92% (£8.3m) delivered to date
▪ Primarily headcount and PLC overhead related
▪ Remainder of savings expected to be delivered in
H2 26
▪ Full year earnings impact in FY27
▪ Targeted EPRA Cost Ratio of <9%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026 Target
Interim results presentation H1 2026
42
Financing – focused on immediate priorities with strong support
from PHP’s lenders
Deleveraging priorities
▪ £103m tranche of primary care assets agreed for
transfer to existing joint venture
Debt maturity profile
▪ Establishment of private hospital joint venture
will raise further proceeds to reduce net debt
0.4
Refinancing priorities
▪ Net proceeds from disposals will be used to
repay portion of variable rate acquisition
facilities and 2027 term loan
▪ Ability to access listed bond market and
establishment of EMTN1 programme
Variable (£bn)
Fixed (£bn)
0.6
To be
repaid
from JV
proceeds
0.5
0.6
▪ Assura’s BBB+ rating reiterated in July 2026
0.0
0.1
2026
2027
0.3
0.5
0.2
0.1
2028
2029
2030
2031
0.1
0.1
0.0
2032
2033
2034
2035
2036
Notes: 1 Euro medium term note.
Interim results presentation H1 2026
43
Financing – facilities and debt metrics
Unsecured facilities
Maturity
Facility
£m
Drawn
£m
100
Backstop facility
Feb-281
264
264
31
31
Barclays Assura loan3
Oct-274
266
266
Sep-28
78
78
Assura public bond 3.0%
Jul-28
300
300
Aviva loan 3.1%
Nov-28
75
75
Term loan3
Jul-282
400
400
Ignis loan note 3.99%
Dec-28
50
50
Club term loan3
Jun-292
300
300
Euro PP (€51m) 2.5%
Dec-28/Dec-30
44
44
Club RCF3
Jun-292
250
200
Euro PP (€70m) 1.51%
Sep-31
60
60
Assura social bond 1.5%
Sep-30
300
300
▪ Individual facilities relating to specific pools of capital
have LTV covenants ranging from 55%-75% and interest
cover ranging from 1.15x-2.25x.
Aviva MXF loan 4.69%
Sep-33
216
216
Club RCF3
Jun-312
250
Euro PP (€47m) 4.2%
Dec-33
41
41
Euro PP (€120m) 3.89%
Nov-32
103
103
▪ Valuations would need to fall by around £1.1bn (37%)
and £1.1bn (34%) across the PHP and Assura portfolios
respectively before LTV covenants are impacted.
Euro PP (€75m) 1.64%
Feb-34
65
65
Assura sust. bond 1.625%
Jun-33
300
300
Aviva loan 2.52%
Oct-36
200
200
Assura US PP 5.6%
Oct-34
60
60
▪ All covenants were complied with during the year.
Total
960
960
Total
2,798
2,493
Jun-26
Dec-25
Secured facilities
Maturity
Facility
£m
Drawn
£m
Net debt to EBITDA
10.4x
10.4x
Secured bond 2.83%
Mar-27
100
Interest cover
2.6x
2.8x
Aviva MXF loan 3.05%
Sep-28
LTV
57%
57%
Std Life loan note 3.55%
Undrawn facilities & cash
£301m
£571m
Unfettered assets
£4,206m
£3,197m
Debt metrics
▪ Under the Backstop facility and new club term loan and
RCF, Group LTV must not exceed 65% of Group property
values.
Notes: Debt drawn adjusted to reflect the new £400m term loan entered into post period end to refinance a corresponding amount of the Backstop facility. Backstop was £664m drawn at 30 June 2026
1 Options to extend to Aug-28. 2 Options to extend by two additional one-year periods, subject to lender approval. 3 Variable rate, subject to hedging where appropriate. 4 Option to extend to 2029.
Interim results presentation H1 2026
44
Asset management – PHP approach drives value
H1 2026 activities
Five completions, exchanged on two new asset
management projects, 21 lease re-gears and 5
new lettings during the first half
▪ £1.7m investment committed
▪ £0.4m increase in rent roll
▪ Lease extended to average of 16 years
Advanced pipeline
PPG Hospital, Birmingham– completed March 2026
120 sqm extension, £1.3m capex
8% yield on cost
Extension to building to allow additional MRI scanner to
be installed and create space for on site imaging analysis.
New equipment brings the latest MRI technology to
enhance the quality of services available to patients.
Additional capacity in region allows NHS, insured and
self pay patients to be seen quicker.
Example of attractive opportunities in private market which
is experiencing sustained growth.
Embrace Medical Centre, Kesgrave – currently on site
PHP approach being applied to enlarged
Group: 68 projects in advanced pipeline
138 sqm extension, £0.9m capex
▪ Provide evidence, alongside developments,
for rent reviews
33% uplift in rent for refurbished space – positive
evidence in region
▪ Targeting increase of c.13% to £218 psm on
these projects
5% yield on cost
Refurbishment and extension, adding 7 new clinical
rooms to support a growing patient list
New 20-year lease, fully compliant with NHS design
guidance
Interim results presentation H1 2026
45
Asset management – PHP approach drives value
Relationship-based approach to collaborate with the local ICB
▪ Recently completed asset management projects at Poole, South
Petherton and Peacemarsh
▪ Each built on strength of relationship with ICB in the local area
▪ PHP has proven track record of improving schemes to meet NHS
requirements and GP demand
▪ Fair uplift in rent for capital invested
▪ Each scheme sets new rent evidence with modest uplift
reflecting build cost inflation
▪ Approach then applied to additional local PHP assets where
additional space required
▪ Currently on site with scheme in Yeovil
▪ Future opportunities at Newton Abbott, Bridport and
Cullompton
Developments
- Fareham – completed
- Shirley – completed
- Winchester – completed
- Weston-super-Mare – on site
Asset management projects
- Poole – completed
- Peacemarsh – completed
- Yeovil – on site
- South Petherton – completed
- Bridport – pipeline
- Cullompton – pipeline
- Newton Abbott – pipeline
10
Bearwood Medical Centre, Poole
£2.3m project to extend building
and convert retail space to clinical.
ROC >10%
Completed September 2025
BREEAM Very Good (expected)
4
8 7
9
3
6
2
5
1
11
▪ Enlarged team from combination, across asset management and
development, has broadened areas of expertise and strength
creating additional opportunities
Interim results presentation H1 2026
46
Development activity
▪ Short-cycle and de-risked development activity: adding high quality assets,
capturing attractive development margins and supporting ESG commitments
▪ Combination with Assura has enhanced development capability and pipeline
▪ A number of potential development opportunities in both the UK and Ireland
and private hospitals continue to be monitored. These will only be progressed
if accretive to earnings
6 completions during 2025 and 2026
▪ Net zero carbon developments at Croft (West Sussex), South Kilburn (London)
and Fareham (Hampshire) plus a GP medical centre in Winchester
(Hampshire)
▪ The Group also completed two primary care centres in Ireland at Ballybay
and Birr
5 development schemes on site
Castlebar
Youghal
Peterborough (private)
Tetbury (JV)
Weston (JV)
Total
Notes: 1 Joint ventures at share
Est.
completion
Q4 26
Q1 27
Q1 27
Q4 26
Q3 27
Total
cost
€16m
€16m
£21m
£1m1
£2m1
£52m
Cost to
complete
€3m
€10m
£12m
£1m1
£1m1
£25m
Yield on
cost
5.3%
4.6%
6.1%
5.5%
5.1%
5.4%
Interim results presentation H1 2026
47
PHP’s approach to ESG
Strategy supports a low carbon approach
▪ Operations, developments and asset
management activities to be NZC by 2030
▪ Operationally light portfolio, assets with low
carbon intensity
▪ Asset management activity supporting carbon
reduction of existing portfolio
▪ Supporting occupiers to be NZC by 2040, 5 years
ahead of NHS’s 2045 target
Strong stewards of underinvested, key
social infrastructure assets
▪ Experience and capital to improve and extend
buildings
▪ 11 million patients or c.15% of UK population
registered at PHP’s buildings
PHP’s net zero carbon (NZC) framework
Continued progress on ESG commitments
2023 Operations to be NZC
▪ Achieved in all years since 2022 using high
quality nature-based carbon offset projects
2025 All new developments to be NZC
▪ Achieved at Croft, West Sussex at South
Kilburn, London and Fareham, Hampshire
2030 All asset management activities to be NZC
and properties to have an EPC of B or better
▪ MEES requirement for all properties
1,000sqm to be EPC B by 2031 – estimated
cost to PHP c.£27m across 175 properties
2035 All buildings to achieve an 80% reduction in
carbon footprint
2040 All buildings are NZC across the portfolio
▪ Strong social focus around good health and
wellbeing
EPC ratings
H1 2026
2025
2024
A
11%
12%
11%
B
53%
51%
36%
C
29%
30%
41%
D
6%
6%
11%
E-F
1%
1%
1%
PHP renewable energy supply
100%
Occupier energy data collected
79%
rating
A
EPRA sBPR rating
CDP rating
rating
Gold
B
Prime
Cost effective improvements through lease
regears
GRESB rating overall score of 59 and
sector leader in healthcare for
development with a 4- star rating
▪ Upgrades to building fabric and systems
improving energy consuming features and
technologies
Committed to Science Based
Targets (SBTi) – being submitted for
validation
▪ LED lights, heat pumps, insulation, solar, electric
vehicle charging
Toitu Carbon Reduce – PHP
disclosed emission data assured
Eastergate, Croft (West Sussex) – PHP’s first NZC development project
Interim results presentation H1 2026
48
Disclaimer
This document comprises the slides for a presentation in respect of Primary Health Properties PLC (the “Company”) (the “Presentation”).
Image list:
No reliance may be placed for any purposes whatsoever on the information in this Presentation or on its completeness. The Presentation is intended to
provide a general overview of the Company’s business and does not purport to deal with all aspects and details regarding the Company. Accordingly, neither
the Company nor any of its directors, officers, employees or advisers nor any other person makes any representation or warranty, express or implied, as to,
and accordingly no reliance may be placed on, the fairness, accuracy or completeness of the information contained in the Presentation, or the views given or
implied. Neither the Company nor any of its directors, officers, employees or advisers nor any other person shall have any liability whatsoever for any errors
or omissions or any loss howsoever arising, directly or indirectly, from any use of this information or its contents or otherwise arising in connection therewith.
Front cover:
Ballincollig ECC, Westfield
Slide 2:
Laya Health & Wellbeing Private Clinic, Cork
Slide 5:
Parkside Hospital, Wimbledon
Slide 7:
Station Medical Centre, Hereford
Slide 13:
Stourside Hospital, Stourbridge
Slide 15:
Shefford Health Centre
This Presentation is not a prospectus or prospectus equivalent document and does not constitute, or form part of, nor is it intended to communicate, any
offer, invitation or inducement to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities of the Company, nor shall it (or any
part of it) or the fact of its distribution, form the basis of, or be relied on in connection with, any contract for any such sale, issue, purchase or subscription.
This Presentation does not constitute a recommendation regarding the Company’s securities. Certain statements in this Presentation regarding the
Company are, or may be deemed to be, forward-looking statements (including such words as “believe”, “expect”, “estimate”, “intend”, “anticipate” and
words of similar meaning). These forward-looking statements are neither historical facts nor guarantees of future performance. Such statements are based
on current expectations and belief and, by their nature, are subject to a number of known and unknown risks, uncertainties and assumptions which may
cause the actual results, events, prospects and developments of the Company and its subsidiaries to differ materially from those expressed or implied by the
forward-looking statements. Forward looking statements contained in this Presentation regarding past trends or activities should not be taken as a
representation that such trends or activities will continue in the future. Except as required by applicable law or regulation, neither the Company nor its
members, directors, officers, employees, agents or representatives undertakes any obligation to update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise.
The contents of the Presentation have not been examined or approved by the Financial Conduct Authority (“FCA”) or London Stock Exchange plc (the
“London Stock Exchange”), nor is it intended that the Presentation will be so examined or approved. The information and opinions contained in the
Presentation are subject to updating, completion, revision, further verification and amendment in any way without liability or notice to any party. No
reliance may be placed for any purpose whatsoever on the information or opinions contained or expressed in the Presentation or on the completeness,
accuracy or fairness of such information and opinions. No undertaking, representation or warranty or other assurance, express or implied, is made or given
as to the accuracy, completeness or fairness of the information or opinions contained or expressed in the Presentation and save in the case of fraud, no
responsibility or liability is accepted by any person for any loss, cost or damage suffered or incurred as a result of the reliance on such information or
opinions. In addition, no duty of care or otherwise is owed by any such person to recipients of the Presentation or any other person in relation to the
Presentation. The material contained in this Presentation reflects current legislation and the business and financial affairs of the Company, which are subject
to change without notice.
This Presentation references information contained in the Interim Results for the first half ended 30 June 2026. No statement in this Presentation is intended
to be a profit forecast and no statement in this Presentation should be interpreted to mean that earnings per Company share for current or future financial
years would necessarily match or exceed the historical published earnings per Company share. Past share performance cannot be relied on as a guide to
future performance.
Fingerpost Medical Centre, St Helens
Fleetwood Health & Wellbeing Centre
Slide 16:
Weston-super-Mare development
Slide 17:
Tetbury development
Slide 18:
Weston-super-Mare, Tetbury & Youghal
Brockworth & Coleford pipeline schemes
Slide 19:
Trinity Medical Centre, Wakefield
Slide 20:
Peterborough development
Slide 21:
Celbridge Primary Care Centre
Slide 22:
St Clement’s Surgery, Winchester
Slide 24:
Shirley Health Partnership, Southampton
Slide 25:
Trinity Medical Centre, Wakefield
Slide 30:
Tetbury development
Slide 31:
Birr Primary Care Centre
Slide 32:
PPG Hospital, Birmingham
Slide 33:
Hadrian Health Centre, Wallsend
Slide 35:
Youghal Primary Care Centre, Ireland
Slide 36:
Peterborough development
Slide 45:
PPG Hospital, Birmingham
Embrace Medical Centre, Kesgrave
Slide 46:
Bearwood Medical Centre, Poole
Slide 47:
Ballybay Primary Care Centre
Slide 48:
Eastergate Medical Centre, West Sussex
Interim results presentation H1 2026
49